Ensaios clínicos de DPOC em Ohio
16 estudos para DPOC estão buscando participantes em locais em Ohio.
Cidades em Ohio
Texto oficial do estudo (Inglês)
To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment
- Remington-Davis Research, Columbus
RecrutandoFase 2
Idades de 40 a 85 · Todos os sexos · Atualizado em 30 de set. de 2026 · NCT07684820A Study of 24 to 52 Weeks Treatment to Evaluate The Efficacy And Safety of Galvokimig in Study Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD) With Chronic Bronchitis
- Copd01 50003, Columbus
RecrutandoFase 2
Idades de 40 a 80 · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT07725939Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
- Dayton Clinical Research- Site Number : 8400124, Dayton
RecrutandoFase 3
Idades de 40 a 80 · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07190209Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
- Asthma & Allergy Center - Toledo- Site Number : 8400110, Toledo
RecrutandoFase 3
Idades de 40 a 80 · Todos os sexos · Atualizado em 15 de set. de 2026 · NCT07190222A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
- Research Site, Cleveland
- Research Site, Marion
RecrutandoFase 2
Idades 40 e acima · Todos os sexos · Atualizado em 9 de set. de 2026 · NCT07082738A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
- Research Site, Columbus
RecrutandoFase 3
Idades de 40 a 80 · Todos os sexos · Atualizado em 3 de set. de 2026 · NCT06883305A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
- Toledo Institute of Clinical Research Inc., Toledo
RecrutandoFase 2/3
Idades de 35 a 80 · Todos os sexos · Atualizado em 31 de ago. de 2026 · NCT07363694A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Research Site, Blue Ash
- Research Site, Columbus
- Research Site, Marion
RecrutandoFase 3
Idades de 40 a 80 · Todos os sexos · Atualizado em 26 de ago. de 2026 · NCT06283966A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
- GC2501 Study Site 104, Cleveland
RecrutandoFase 3
Idades de 18 a 80 · Todos os sexos · Atualizado em 11 de ago. de 2026 · NCT07555483Multi-Center Clean Air Randomized Controlled Trial in COPD
- Cleveland Clinic, Cleveland
RecrutandoFase 3
Idades 40 e acima · Todos os sexos · Atualizado em 31 de jul. de 2026 · NCT06376994PEP Buddy in Pulmonary Rehabilitation
- Cincinnati VA Medical Center, Cincinnati, OH, Cincinnati
- Louis Stokes VA Medical Center, Cleveland, OH, Cleveland
Recrutando
Idades de 40 a 89 · Todos os sexos · Atualizado em 24 de jul. de 2026 · NCT07404826Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD
- Ohio State University Medical Center - Ohio State Lung Center, Columbus
Recrutando
Idades de 40 a 80 · Todos os sexos · Atualizado em 28 de abr. de 2026 · NCT07051707Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
- Cleveland Clinic Foundation, Cleveland
- The Ohio State University, Columbus
Recrutando
Idades de 40 a 84 · Todos os sexos · Atualizado em 24 de abr. de 2026 · NCT06891755Implementation of a Sarcopenia Clinic to Diagnose and Treat Skeletal Muscle Loss Due to COPD
- Cleveland Clinic Foundation, Cleveland
Recrutando
Idades 40 e acima · Todos os sexos · Atualizado em 30 de out. de 2025 · NCT07059637myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home
- Cincinnati VA Medical Center, Cincinnati
- Cleveland Clinic Foundation, Cleveland
- Ohio State University Wexner Medical Center, Columbus
Recrutando
Idades 30 e acima · Todos os sexos · Atualizado em 6 de fev. de 2025 · NCT05204888PRagmatic EVAluation of a Quality Improvement Program for People Living With Modifiable High-risk COPD.
- MetroHealth, Cleveland
Recrutando
Idades 18 e acima · Todos os sexos · Atualizado em 12 de out. de 2023 · NCT05306743Fonte: ClinicalTrials.gov, dados obtidos em 1 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.